Cargando…
Liver Transplantation for Homozygous Familial Hypercholesterolemia
Pharmacological treatments to decrease low-density lipoprotein (LDL) cholesterol (LDL-C) have limited effects on patients with homozygous familial hypercholesterolemia (HoFH). Since LDL receptors are located mainly in the liver, liver transplantation is considered to be the only way to correct the h...
Autores principales: | Ishigaki, Yasushi, Kawagishi, Naoki, Hasegawa, Yutaka, Sawada, Shojiro, Katagiri, Hideki, Satomi, Susumu, Oikawa, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365147/ https://www.ncbi.nlm.nih.gov/pubmed/30555131 http://dx.doi.org/10.5551/jat.RV17029 |
Ejemplares similares
-
Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021) -
Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012) -
Advancements in the Treatment of Homozygous Familial Hypercholesterolemia
por: Bajaj, Archna, et al.
Publicado: (2022) -
Perioperative Management and Clinical Outcomes of Liver Transplantation for Children with Homozygous Familial Hypercholesterolemia
por: Qiu, Huan-Rong, et al.
Publicado: (2022) -
Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)